Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,600.00p
   
  • Change Today:
    -20.00p
  • 52 Week High: 2,715.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 60,876
  • Market Cap: £1,729.98m
  • RiskGrade: 128

Latest ShareCast News

Berenberg starts Genus at 'buy', cites protein demand and China opportunity

By Iain Gilbert

Date: Wednesday 26 Nov 2025

(Sharecast News) - Analysts at Berenberg initiated coverage on genetics firm Genus with a 'buy' rating and a 3,050p target price on Wednesday, stating the "long-term underlying dynamics" of the business "look attractive".

Genus Regulatory News

Director/PDMR Shareholding 27-Nov-2025 07:00 RNS
Results of AGM 19-Nov-2025 12:12 RNS
Non-Executive Director Appointments 19-Nov-2025 07:00 RNS
AGM Trading Update 19-Nov-2025 07:00 RNS
Total Voting Rights 03-Nov-2025 10:56 RNS

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,600.00p
Change Today -20.00p
% Change -0.76 %
52 Week High 2,715.00
52 Week Low 1,424.00
Volume 60,876
Shares Issued 66.54m
Market Cap £1,729.98m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 09-Dec-2025

Time Volume / Share Price
11:45 255 @ 2,600.00p
11:45 13 @ 2,600.00p
11:45 224 @ 2,600.00p
11:45 2 @ 2,600.00p
11:45 1 @ 2,600.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page